Article

(2021) Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. eLife.

(2020) 4-Oxobenzod1,2,3-triazin-pyridinium-phenylacetamide derivatives as new anti-Alzheimer agents: design, synthesis, in vitro evaluation, molecular modeling, and molecular dynamic study. Structural Chemistry. pp. 999-1012.

(2020) Repositioning of the global epicentre of non-optimal cholesterol. Nature. pp. 73-77.

(2019) Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease. Chemistry & biodiversity. p. 13. ISSN 1612-1872

(2019) Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-<i>N</i>-morpholine Hybrids as New Anti-Alzheimer Agents. Chemistry & biodiversity. p. 8. ISSN 1612-1872

(2019) Design, synthesis, and biological evaluation of novel 4-oxobenzo <i>d</i> 1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents. Bioorganic & medicinal chemistry. pp. 2914-2922. ISSN 0968-0896

(2019) Household socioeconomic status in relation to childhood general and central obesity in Farrokhshahr, Iran. ARYA Atherosclerosis. pp. 211-217. ISSN 1735-3955

(2019) New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study. Bioorganic Chemistry. pp. 506-515. ISSN 0045-2068

(2018) Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Archiv der Pharmazie. ISSN 03656233 (ISSN)